Concepedia

Jean‐François Tamby

JT

13

Publications

4.3K

Citations

12

H-Index

2000

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Sanofi (United States)

Leiden University Medical Center

Oregon Health & Science University

Jean‐François Tamby is an author at Brigham and Women's Hospital specializing in pharmacotherapy, medicine, and pharmacology.

Top concepts

Publications per year

2000–2025

13

Publications

13

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Gregory G. Schwartz, Philippe Gabríel Steg, Michael Szarek et al. · New England Journal of Medicine · 2018 · 3.3K citations · Full text

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Gregory G. Schwartz, Laurence Bessac, Lisa G. Berdan et al. · American Heart Journal · 2014 · 409 citations · Full text

Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study

Walter H. Gotlieb, Frédéric Amant, Suresh H. Advani et al. · The Lancet Oncology · 2011 · 151 citations

, , +9

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 112 citations · Full text

Effects of Danicamtiv, a Novel Cardiac Myosin Activator, in Heart Failure with Reduced Ejection Fraction: Experimental Data and Clinical Results from a Phase 2a Trial

Adriaan A. Voors, Jean‐François Tamby, John G.F. Cleland et al. · European Journal of Heart Failure · 2020 · 98 citations · Full text

Rows per page

1–5 of 13